Showing results (111-120 of 220) with videos related to

Sort By:
Pageof 22
Leukemia|June 4, 2014
Comparison of minimal residual disease as outcome predictor for AML patients in first complete remission undergoing myeloablative or nonmyeloablative allogeneic hematopoietic cell transplantationR B Walter, B Gyurkocza, B E Storer, et al.
Bioconjugate Chemistry|July 6, 2010
Design and synthesis of bis-biotin-containing reagents for applications utilizing monoclonal antibody-based pretargeting systems with streptavidin mutantsD Scott Wilbur, Steven I Park, Ming-Kuan Chyan, et al.
JMIR Research Protocols|October 8, 2025
Evaluating the Efficacy of a Mobile Phone App in Enhancing Menopause Knowledge and Shared Decision-Making: Protocol for a Randomized Controlled TrialJana Karam, Maggie M Paul, Chrisandra Shufelt, et al.
American Journal of Hematology|February 18, 2015
Idarubicin, cytarabine, and pravastatin as induction therapy for untreated acute myeloid leukemia and high-risk myelodysplastic syndromeMazyar Shadman, Raya Mawad, Carol Dean, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 5, 2019
Phase I Study of a CD45-Targeted Antibody-Radionuclide Conjugate for High-Risk LymphomaRyan D Cassaday, Oliver W Press, John M Pagel, et al.
Cancer Biotherapy & Radiopharmaceuticals|May 6, 2008
Extracorporeal adsorption therapy: a method to improve targeted radiation delivered by radiometal-labeled monoclonal antibodiesEneida R Nemecek, Damian J Green, Darrell R Fisher, et al.
British Journal of Haematology|November 17, 2015
Phase II study of tosedostat with cytarabine or decitabine in newly diagnosed older patients with acute myeloid leukaemia or high-risk MDSRaya Mawad, Pamela S Becker, Paul Hendrie, et al.
Journal of Clinical and Translational Science|July 16, 2021
Evaluation of the academic achievements of clinician health services research scientists involved in "pre-K" career development award programsErin F Barreto, Rozalina G McCoy, Joseph J Larson, et al.
Blood|July 13, 2013
Significance of minimal residual disease before myeloablative allogeneic hematopoietic cell transplantation for AML in first and second complete remissionRoland B Walter, Sarah A Buckley, John M Pagel, et al.
Bone Marrow Transplantation|October 9, 2007
The impact of histologic grade on the outcome of high-dose therapy and autologous stem cell transplantation for follicular lymphomaR N Pham, T A Gooley, G E Keeney, et al.
Pageof 22